CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Performance evaluation of vitros® anti-sars cov-2 antibody assays (total & igg): an adjunctive screening tool for rtqpcr in covid–19 infection detection

Author: 
Dr. Manushri Sharma, Dr. Amardeep Pathak and Dr. Anurag Mehta
Subject Area: 
Health Sciences
Abstract: 

Background: Currently world is facing a pandemic caused by novel corona virus (SARS –CoV2) which causes a highly contagious infection affecting most commonly lungs and results in an array of clinical symptoms ranging from asymptomatic state to acute respiratory distress syndrome and may even lead to multi organ dysfunction.The diagnostic modalities include Reverse transcriptase real time PCR (RTqPCR) which is gold standard method for diagnosis of the infection using oro-pharyngeal or nasopharyngeal swabs from the patients. Aim and Objectives: Evaluation of the performance of VITROS® Anti SARS CoV-2 antibody Assays (Total &IgG) in RT-PCR positive symptomatic COVID -19 patients.A correlation of time gap between RTqPCR/CB-NAT tests and positive serology test will be done for Total antibody. Materials and Method: Blood samples of COVID 19 confirmed patients (by RTqPCR) were tested for Anti SARS CoV2 Total (IgM, IgG&IgA) (ASCV2T). All these ASCV2T positive samples were further tested for Anti SARS CoV2 IgG (ASCV2G) antibodies using VITROS® 3600 immunodiagnostics system as per the manufacturer protocol. Results: A total of 67 patient samples were collected in the period of 02 months from June 2020 & July 2020. Out of these 67 patients 34 were positive and 33 were negative for COVID-19 infection by RTqPCR method. 28 of the 34 RTqPCR positive samples were reactive for total antibody test. As per statistical analysis, ASCV2T assay showed sensitivity 82.35%, specificity 100%, PPV 100%& NPV 84.62%. Conclusion: Serological assay show fair sensitivity (82.35%) & specificity (100%). Both RTqPCR& serological assay as a combination can be used as an important screening tool for COVID 19 infection. This can be further validated by Randomized controlled trails or meta-analysis with large number of sample size for longer duration follow-up.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran